In relation to potential share price, GRY is exploring in the same area and there's no reason why MET can't follow the same price trajectory ;)
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025